During the past few years, we have witnessed a bumper crop of bright naked-eye comets, beckoning us to set up a camera and record their beauty to share with friends and family. However, the next great ...

AstraZeneca’s Tagrisso could face some serious competition as a first-line targeted therapy for advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC), in the shape of a new two-drug ...